Home / Stocks / ELVN

ELVN insider trading

Enliven Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy
—

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-06Derynck Mika K
Director
Sold158,795$60.21$9.6M
2026-06-24ORBIMED ADVISORS LLC
10% owner
Sold858,646$45.36$38.9M
2026-06-17ORBIMED ADVISORS LLC
10% owner
Sold272,322$45.02$12.3M
2026-03-27Collins Helen Louise
CHIEF MEDICAL OFFICER
Sold40,000$35.10$1.4M
2026-02-19Collins Helen Louise
CHIEF MEDICAL OFFICER
Sold45,000$26.17$1.2M
2026-01-13Patel Anish
CHIEF OPERATING OFFICER
Sold48,057$27.98$1.3M
2026-01-12Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sold91,198$27.22$2.5M

See ELVN on the chart

Every insider buy and sell for ELVN plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.